 |
|
|
 |
|
Stephen M. Prescott, M.D.
|
|
| |
Chairman, LineaGen Board of Directors
President, Oklahoma Medical Research Foundation |
| |
|
| |
Dr. Prescott became president of the Oklahoma Medical Research Foundation (OMFR) in the spring of 2006. A global leader in studies of the basic mechanisms of human disease, Dr. Prescott came to OMRF from the University of Utah, where he founded the innovative Eccles Program in Human and Molecular Biology & Genetics, which applies the methods of genetics and molecular biology to problems of human disease. He served as the executive director of the University of Utah's Huntsman Cancer Institute from 1999 through 2005. |
| |
|
|
| |
At the Huntsman Cancer Institute, Dr. Prescott raised $180 million in private contributions and secured more than $100 million in government funding. He expanded the institute with the addition of dozens of new researchers and the construction of the Huntsman Cancer Hospital, a 330,000-square-foot comprehensive cancer treatment facility. Under Dr. Prescott's leadership, the institute was designated the official cancer center of Utah by the state legislature. |
|
| |
|
|
| |
A native of Texas and a Texas A&M University undergraduate, Dr. Prescott received his MD from Baylor College of Medicine prior to completing his training in internal medicine at the University of Utah. He then undertook advanced research training at Washington University School of Medicine in St. Louis. In 1982, Dr. Prescott joined the faculty of the University of Utah, where he became a professor of internal medicine and held the H.A. & Edna Benning Presidential Endowed Chair. He has authored more than 250 scientific articles and has trained over 40 students and postdoctoral fellows from around the world. |
|
| |
|
|
| |
Dr. Prescott served as a senior editor of the influential Journal of Biological Chemistry and serves on the board of the Journal of Clinical Investigation. He has also served on medical and scientific advisory committees for the National Institutes of Health, the American Heart Association and multiple universities. He has been elected as a fellow of the American Association for the Advancement of Science and as a member of the Association of American Physicians, the American Society for Clinical Investigation, the Royal College of Physicians in Ireland, and the Royal Academy of Medicine in Spain. Dr. Prescott has been a member of the board of the American Red Cross Biomedical Division and is a member of the National Human Genome Research Institute's Advisory Council. He was a member of the Institute of Medicine Committee on Large-Scale Science and Cancer Research, and chaired the Utah Governor's Task Force on Technology Transfer. Among other awards, he has received the Utah Governor's Medal for Science and Technology, the Houssay-Braun-Menendez Medal from the Argentine Association for the Advancement of Science, and the Sol Sherry Prize from the American Heart Association.
|
|
| |
Dr. Prescott has worked as a consultant for pharmaceutical and biotechnology companies in the United States, Europe and Japan, and has served on the scientific advisory board or board of directors of four biotechnology companies. He is a co-founder of LineaGen. |
|
|
|
|
|
|
|
|